GLMD
Galmed Pharmaceuticals Ltd.Company with tickers: GLMD
CIK
1595353
CUSIP
M47238148
Shares Outstanding
7,684,074
Website
https://galmedpharma.com
Investor Relations
https://galmedpharma.com/investors/
13F Activity (30d)
2 filings
1 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 20-F | 2020-03-12 | 2019-12-31 | |
| 6-K | 2020-03-12 | — | |
| 6-K | 2020-05-14 | — | |
| 6-K | 2020-05-15 | — | |
| 6-K | 2020-05-18 | — | |
| 6-K | 2020-05-21 | — | |
| 6-K | 2020-06-19 | — | |
| 6-K | 2020-07-08 | — | |
| 6-K | 2020-08-06 | 2020-06-30 | |
| 6-K | 2020-08-14 | — | |
| 6-K | 2020-09-09 | — | |
| 6-K | 2020-11-09 | — | |
| 6-K | 2020-11-12 | — | |
| 6-K | 2020-12-17 | — | |
| 6-K | 2021-01-26 | — | |
| 6-K | 2021-02-16 | — | |
| 6-K | 2021-02-18 | — | |
| 6-K | 2021-03-16 | — | |
| 6-K | 2021-03-18 | — | |
| 20-F | 2021-03-18 | 2020-12-31 | |
| 6-K | 2021-03-26 | — | |
| 6-K | 2021-05-03 | — | |
| 6-K | 2021-05-13 | — | |
| 6-K | 2021-07-02 | — | |
| 6-K | 2021-07-19 | — | |
| 6-K | 2021-08-02 | — | |
| 6-K | 2021-08-05 | 2021-06-30 | |
| 6-K | 2021-08-16 | — | |
| 6-K | 2021-08-19 | — | |
| 6-K | 2021-08-23 | — | |
| 6-K | 2021-08-31 | — | |
| 6-K | 2021-10-12 | — | |
| 6-K | 2021-11-01 | — | |
| 6-K | 2021-11-08 | — | |
| 6-K | 2022-01-10 | — | |
| 6-K | 2022-01-11 | — | |
| 6-K | 2022-03-03 | — | |
| 6-K | 2022-04-28 | — | |
| 20-F | 2022-05-02 | 2021-12-31 | |
| 6-K | 2022-05-02 | — | |
| 6-K | 2022-05-17 | — | |
| 6-K | 2022-06-17 | — | |
| 6-K | 2022-06-22 | — | |
| 6-K | 2022-06-29 | — | |
| 6-K | 2022-07-07 | — | |
| 6-K | 2022-08-04 | 2022-06-30 | |
| 6-K | 2022-11-16 | — | |
| 6-K | 2022-12-14 | — | |
| 6-K | 2023-01-04 | — | |
| 6-K | 2023-01-05 | — |
Showing 1–50 of 122 filings